Allergen-specific intralymphatic immunotherapy in human and animal studies
Asia Pacific Allergy
;
(4): 131-137, 2017.
Artigo
em Inglês
| WPRIM
| ID: wpr-750110
ABSTRACT
Clinical trials of intralymphatic immunotherapy (ILIT) have been performed to overcome the limitations of long-term therapy and the local or systemic hypersensitivity reactions in conventional allergen-specific immunotherapy, including subcutaneous or sublingual immunotherapy. Additionally, several animal studies of ILIT have been conducted in the form of translational or veterinary research. We conducted a literature review to examine the treatment efficacy and adverse effects of ILIT.
Texto completo:
DisponíveL
Índice:
WPRIM (Pacífico Ocidental)
Assunto principal:
Resultado do Tratamento
/
Imunoterapia Sublingual
/
Hipersensibilidade
/
Imunoterapia
/
Injeções Intralinfáticas
Limite:
Animais
/
Humanos
Idioma:
Inglês
Revista:
Asia Pacific Allergy
Ano de publicação:
2017
Tipo de documento:
Artigo
Similares
MEDLINE
...
LILACS
LIS